Menu Back to 02-Disruptive-Innovation

Track 2: Disruptive Innovation

DIA 2017: Driving Insights to Action! 

With 13 sessions specific to Disruptive Innovation, this track focuses on innovations that drive new markets and value networks in the biopharmaceutical industry. Covering topics from leveraging wearables and new frontiers in pharmaceutical manufacturing, to artificial intelligence in clinical trials, this Core Interest Area will ensure you are up-to-date on the latest clinical, scientific, and medical research topics and applications.

Highlights in Disruptive Innovation

  • The ways in which artificial intelligence (AI) can impact clinical decision-making and how we design and run clinical trials
  • How effective or robust is AI 
  • Endpoint structures developed to capture disease status and medical product performance, while still allowing interpretability
  • The complexity of the microbiome in conducting clinical research and monitoring
  • The potential of 3D printing and how it can provide personalized medicine within clinical trials and on the market
  • Sophisticated predictive analytic tools and how they transform product development and supply
  • Featured Topics in Career Development and Wearables/Mobile Health

DIA recommends this track and associated sessions to professionals involved in: regulatory, clinical operations, safety and pharmacovigilance, medical affairs, and data management.

Sessions in Disruptive Innovation

Monday, June 19

Tuesday, June 20

Wednesday, June 21

Thursday, June 22


Registration Rates

Back to DIA 2017

Back to DIAglobal.org